Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  2017-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.numecd.2017.04.009PMID 28709719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of metformin on blood pressure in nondiabetic patients: a meta-analysis of randomized controlled trials

  2017cited by this paper
• SIRT3–AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction

  2016cited by this paper
• Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition

  2016cited by this paper
• Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro

  2016cited by this paper
• Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies

  2016cited by this paper
• Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus

  2016cited by this paper
• Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.

  2016cited by this paper
• Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.

  2016cited by this paper
• Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms.

  2016cited by this paper
• Sumatriptan Patch is Temporarily Suspended.

  2016cited by this paper
• Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

  2016cited by this paper
• The FDA Revises Restrictions on Metformin Use in Kidney Impairment.

  2016cited by this paper
• Protective Effect of Metformin against Acute Inflammation and Oxidative Stress in Rat

  2016cited by this paper
• Fuel availability and fate in cardiac metabolism: A tale of two substrates.

  2016cited by this paper
• Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling

  2016cited by this paper
• Cardiovascular Protective Effect of Metformin and Telmisartan: Reduction of PARP1 Activity via the AMPK-PARP1 Cascade

  2016cited by this paper
• ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content

  2015cited by this paper
• Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

  2015cited by this paper
• Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial.

  2015cited by this paper
• Pleiotropic Benefits of Metformin: Macrophage Targeting Its Anti-inflammatory Mechanisms

  2015cited by this paper
• Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1β (IL-1β) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages*

  2015cited by this paper
• Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study.

  2015cited by this paper
• Metformin and Myocardial Injury in Patients With Diabetes and ST‐Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis

  2015cited by this paper
• Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats

  2015cited by this paper
• Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial

  2014cited by this paper
• Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria

  2014cited by this paper
• Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells

  2014cited by this paper
• Metformin exaggerates phenylephrine-induced AMPK phosphorylation independent of CaMKKβ and attenuates contractile response in endothelium-denuded rat aorta.

  2014cited by this paper
• Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

  2014cited by this paper
• Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis

  2014cited by this paper
• AMPK activation: a therapeutic target for type 2 diabetes?

  2014cited by this paper
• Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial.

  2014cited by this paper
• Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells.

  2014cited by this paper
• Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.

  2014cited by this paper
• Metformin mitigates apoptosis in ischemic myocardium.

  2014cited by this paper
• Metformin Inhibits Monocyte-to-Macrophage Differentiation via AMPK-Mediated Inhibition of STAT3 Activation: Potential Role in Atherosclerosis

  2014cited by this paper
• Metformin Protects Against Systolic Overload–Induced Heart Failure Independent of AMP-Activated Protein Kinase &agr;2

  2014cited by this paper
• Chronic Metformin Treatment is Associated with Reduced Myocardial Infarct Size in Diabetic Patients with ST-segment Elevation Myocardial Infarction

  2014cited by this paper
• Metformin affects macrophages’ phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages

  2014cited by this paper
• Metformin Suppresses Lipopolysaccharide (LPS)-induced Inflammatory Response in Murine Macrophages via Activating Transcription Factor-3 (ATF-3) Induction*

  2014cited by this paper
• Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial.

  2014cited by this paper
• Protective Effect of Metformin on Myocardial Injury in Metabolic Syndrome Patients following Percutaneous Coronary Intervention

  2013cited by this paper
• Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.

  2013cited by this paper
• Metformin's potential in oncology.

  2013cited by this paper
• Impact of sex on the heart's metabolic and functional responses to diabetic therapies.

  2013cited by this paper
• C-Peptide Activates AMPKα and Prevents ROS-Mediated Mitochondrial Fission and Endothelial Apoptosis in Diabetes

  2013cited by this paper
• The antidiabetic gutsy role of metformin uncovered?

  2013cited by this paper
• Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

  2013cited by this paper
• Glucose Regulation of Load‐Induced mTOR Signaling and ER Stress in Mammalian Heart

  2013cited by this paper
• AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition.

  2013cited by this paper
• Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin–sensitizing effects of metformin

  2013cited by this paper
• Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon

  2013cited by this paper
• Relationship between high values of HOMA-IR and cardiovascular response to metformin.

  2013cited by this paper
• Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community.

  2013cited by this paper
• An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice

  2013cited by this paper
• Metformin improves healthspan and lifespan in mice

  2013cited by this paper
• Comparative Safety and Effectiveness of Metformin in Patients With Diabetes Mellitus and Heart Failure: Systematic Review of Observational Studies Involving 34 000 Patients

  2013cited by this paper
• Potential applications for biguanides in oncology.

  2013cited by this paper
• Reappraisal of Metformin Efficacy in the Treatment of Type 2 Diabetes: A Meta-Analysis of Randomised Controlled Trials

  2012cited by this paper
• Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats

  2012cited by this paper
• Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults

  2012cited by this paper
• The effect of metformin on insulin resistance and exercise parameters in patients with heart failure

  2012cited by this paper
• Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model

  2012cited by this paper
• Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.

  2011cited by this paper
• A Novel Cardioprotective Agent in Cardiac Transplantation: Metformin Activation of AMP-Activated Protein Kinase Decreases Acute Ischemia-Reperfusion Injury and Chronic Rejection

  2011cited by this paper
• AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.

  2011cited by this paper
• Profibrinolytic, Antithrombotic, and Antiinflammatory Effects of an Insulin-Sensitizing Strategy in Patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

  2011cited by this paper
• Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice

  2011cited by this paper
• The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

  2011cited by this paper
• Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

  2011cited by this paper
• Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study

  2011cited by this paper
• Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats.

  2011cited by this paper
• Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

  2011cited by this paper
• Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase.

  2011cited by this paper
• Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials

  2011cited by this paper
• Metformin improves cardiac function in rats via activation of AMP‐activated protein kinase

  2011cited by this paper
• Metformin attenuates ventricular hypertrophy by activating the AMP‐activated protein kinase–endothelial nitric oxide synthase pathway in rats

  2011cited by this paper
• AMP-activated protein kinase and its downstream transcriptional pathways

  2010cited by this paper
• Metformin Activates AMP Kinase through Inhibition of AMP Deaminase

  2010cited by this paper
• Increased Glycation and Oxidative Damage to Apolipoprotein B100 of LDL Cholesterol in Patients With Type 2 Diabetes and Effect of Metformin

  2010cited by this paper
• Metformin Use and Mortality in Ambulatory Patients With Diabetes and Heart Failure

  2010cited by this paper
• Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

  2010cited by this paper
• Metformin in polycystic ovary syndrome

  2010cited by this paper
• Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1

  2010cited by this paper
• Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus.

  2010cited by this paper
• Metformin use and mortality among patients with diabetes and atherothrombosis.

  2010cited by this paper
• Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.

  2010cited by this paper
• Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple Sclerosis1

  2009cited by this paper
• Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus

  2009cited by this paper
• Metformin Prevents Progression of Heart Failure in Dogs: Role of AMP-Activated Protein Kinase

  2009cited by this paper
• Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor

  2009cited by this paper
• In Vivo Metabolic Phenotyping of Myocardial Substrate Metabolism in Rodents: Differential Efficacy of Metformin and Rosiglitazone Monotherapy

  2009cited by this paper
• Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.

  2009cited by this paper
• Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure

  2009cited by this paper
• A randomized trial of therapies for type 2 diabetes and coronary artery disease.

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Acute Metformin Therapy Confers Cardioprotection Against Myocardial Infarction Via AMPK-eNOS–Mediated Signaling

  2008cited by this paper
• Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

  2008cited by this paper
• Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.

  2008cited by this paper
• Effects of metformin on QT and QTc interval dispersion of diabetic rats.

  2008cited by this paper

• Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection

  2025cites this paper
• Exploring multifaceted roles of metformin in therapeutic applications, mechanistic insights, and innovations in drug delivery systems across biological contexts: a systematic review

  2025cites this paper
• Metformin activates autophagy and inhibits apoptosis and fetal heart abnormalities via the Dnmt3l/Usp18/STAT1 pathway.

  2025cites this paper
• The effect of extended release metformin on MRI parameters of left ventricular remodeling in patients with prediabetes and heart failure with preserved ejection fraction

  2025cites this paper
• Metformin and Risks of Aortic Aneurysm and Aortic Dissection: A Mendelian Randomization Study

  2025cites this paper
• Ameliorative effects of combination therapy with metformin and crocin in experimental colitis in rats

  2025cites this paper
• The impact of metformin on myocardial hypertrophy: an updated systematic review, meta-analysis, and meta-regression of randomized controlled trials

  2025cites this paper
• Windows of Susceptibility to Air Pollution During and Surrounding Pregnancy in Relation to Longitudinal Maternal Measures of Adiposity and Lipid Profiles.

  2025cites this paper
• Potential Molecular Biomarkers for Predicting and Monitoring Complications in Type 2 Diabetes Mellitus

  2025cites this paper
• Pharmacological and Herbal Approach to Diabetes Mellitus Type 2 Management: A Comparative Analysis of Conventional Therapy and Alternative Remedy.

  2025cites this paper
• Regenerative therapies for myocardial infarction: exploring the critical role of energy metabolism in achieving cardiac repair

  2025cites this paper
• LEP and FOXO1 genes, as a proposed tumor suppressor autophagic cell death related genes, can be targeted by antidiabetic therapy in nondiabetic breast cancer patients

  2025cites this paper
• Association between metformin use and reduced short- and long-term all-cause mortality in patients undergoing cardiac surgery: a retrospective cohort study

  2025cites this paper
• Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania

  2024cites this paper
• Biochemical bases of the organoprotective properties of metformin

  2024cites this paper
• Zbtb16 increases susceptibility of atrial fibrillation in type 2 diabetic mice via Txnip-Trx2 signaling

  2024cites this paper
• Collaboration of alogliptin and pioglitazone: a double hit on the target

  2024cites this paper
• Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis

  2024cites this paper
• The dental perspective on metformin

  2024cites this paper
• The impact of empagliflozin and metformin on cardiac parameters in patients with mid-range ejection fraction heart failure without diabetes

  2024cites this paper
• Interactions between antidiabetes medications and heart–brain axis

  2024cites this paper
• AMP‐dependent kinase stimulates the expression of αKlotho

  2024cites this paper
• Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats

  2024cites this paper
• Metformin's dual impact on Gut microbiota and cardiovascular health: A comprehensive analysis.

  2024cites this paper
• Advancing Longevity: Exploring Antiaging Pharmaceuticals in Contemporary Clinical Trials Amid Aging Dynamics

  2024cites this paper
• Metformin regulates cellulase production in Trichoderma reesei via calcium signaling and mitochondrial function

  2024cites this paper
• Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association

  2023cites this paper
• Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study

  2023cites this paper
• mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy

  2023cites this paper
• Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury.

  2023cites this paper
• Metformin enhances neural precursor cells migration and functional recovery after ischemic stroke in mice

  2023cites this paper
• Effect of metformin (vs. placebo or sulfonylurea) on all-cause and cardiovascular mortality and incident cardiovascular events in patients with diabetes: an umbrella review of systematic reviews with meta-analysis

  2023cites this paper
• Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers

  2023cites this paper
• Metformin and sitagliptin fixed combination as the optimal choice in solving current problems in the type 2 diabetes mellitus treatment

  2023cites this paper
• Effects of Sodium-Glucose Cotransporter Inhibitor Use in Type 2 Diabetes Mellitus Patients With Heart Failure

  2023cites this paper
• Metformin adherence reduces the risk of dementia in patients with diabetes: A population-based cohort study.

  2023cites this paper
• Impaired end joining induces cardiac atrophy in a Hutchinson–Gilford progeria mouse model

  2023cites this paper
• Effect of Metformin on Oxidative Stress and Left Ventricular Geometry in Nondiabetic Heart Failure Patients: A Randomized Controlled Trial

  2023cites this paper
• Metformin and sitagliptin fixed combination as the optimal choice in solving current problems in the type 2 diabetes mellitus treatment

  2023cites this paper
• Three-Dimensional Stretchable Sensor-Hydrogel Integrated Platform for Cardiomyocyte Culture and Mechanotransduction Monitoring.

  2023cites this paper
• Comparison of long-term effects of metformin on longevity between people with type 2 diabetes and matched non-diabetic controls

  2023cites this paper
• Metformin Inhibits Autophagy, Mitophagy and Antagonizes Doxorubicin-Induced Cardiomyocyte Death

  2023cites this paper
• Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review

  2023cites this paper
• New Tale of Metformin in Cardio-Oncology

  2023cites this paper
• Metformin effects on cardiac parameters in non-diabetic Iraqi patients with heart failure and mid-range ejection fraction – a comparative two-arm parallel clinical study

  2023cites this paper
• Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation

  2023cites this paper
• Insulin resistance and heart failure with preserved ejection fraction. Pathogenetic and therapeutic crossroads

  2022cites this paper
• The effect of metformin on cardiovascular markers in female mice consuming a high fat diet.

  2022cites this paper
• Justicia carnea extracts ameliorated hepatocellular damage in streptozotocin-induced type 1 diabetic male rats via decrease in oxidative stress, inflammation and increasing other risk markers

  2022cites this paper
• Metformin therapy as a strategy to compensate anti-VEGF resistance in patients with diabetic macular edema

  2022cites this paper
• Cellular senescence and cardiovascular diseases: moving to the "heart" of the problem.

  2022cites this paper
• Effect of metformin on left ventricular mass and functional parameters in non-diabetic patients: a meta-analysis of randomized clinical trials

  2022cites this paper
• Breast milk mesenchymal stem cells abate cisplatin-induced cardiotoxicity in adult male albino rats via modulating the AMPK pathway

  2022cites this paper
• Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease

  2022influential citation
• Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications

  2022cites this paper
• Effects of curcumin and metformin on oxidative stress and apoptosis in heart tissue of type 1 diabetic rats

  2022cites this paper
• Association of metformin treatment with enhanced effect of anti-VEGF agents in diabetic macular edema patients

  2022cites this paper
• Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes

  2022cites this paper
• Comparison between Policaptil Gel Retard and Metformin by Testing of Temporal Changes in Patients with Metabolic Syndrome and Type 2 Diabetes

  2022cites this paper
• The Function of Metformin in Aging-Related Musculoskeletal Disorders

  2022cites this paper
• The impact of metformin on cardiac troponin-I and ST resolution in patients with ST elevation myocardial infarction undergoing thrombolytic therapy

  2022cites this paper
• Structural Comparison of Sulfonamide-Based Derivatives That Can Improve Anti-Coagulation Properties of Metformin

  2022cites this paper
• Evaluating the cardioprotective effect of metformin on myocardial ischemia–reperfusion injury using dynamic 18F-FDG micro-PET/CT imaging

  2022cites this paper
• Type 2 Diabetes Complicated With Heart Failure: Research on Therapeutic Mechanism and Potential Drug Development Based on Insulin Signaling Pathway

  2022cites this paper
• Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure.

  2022cites this paper
• Mitochondria as an important target of metformin: the mechanism of action, toxic and side effects, and new therapeutic applications.

  2022cites this paper
• Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis

  2022cites this paper
• Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity

  2022cites this paper
• Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis

  2022cites this paper
• Vascular diseases

  2022cites this paper
• Metformin ameliorates polycystic ovary syndrome in a rat model by decreasing excessive autophagy in ovarian granulosa cells via the PI3K/AKT/mTOR pathway.

  2022cites this paper
• Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumors.

  2022cites this paper
• Metformin and arsenic trioxide synergize to trigger Parkin/pink1-dependent mitophagic cell death in human cervical cancer HeLa cells

  2021cites this paper
• Kolaviron attenuates cardiovascular injury in fructose-streptozotocin induced type-2 diabetic male rats by reducing oxidative stress, inflammation, and improving cardiovascular risk markers.

  2021cites this paper
• A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19

  2021cites this paper
• Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway

  2021cites this paper
• The metabolic signatures of cardiometabolic diseases: Does the shared metabotype offer new therapeutic targets?

  2021cites this paper
• Prestroke Metformin Use on the 1-Year Prognosis of Intracerebral Hemorrhage Patients with Type 2 Diabetes

  2021cites this paper
• Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice

  2021cites this paper
• Effect of metformin on 18F-fluorodeoxyglucose uptake and positron emission tomographic imaging.

  2021cites this paper
• Metformin and Sildenafil Attenuate Inflammation and Suppress Apoptosis After Ischemia/Reperfusion Injuries in Rat Urinary Bladder

  2021cites this paper
• The effects of metformin on autophagy.

  2021cites this paper
• Metformin relieves H/R-induced cardiomyocyte injury through miR-19a/ACSL axis - possible therapeutic target for myocardial I/R injury.

  2021cites this paper
• Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence

  2021cites this paper
• Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug

  2021cites this paper
• Metformin alleviates monoamine oxidase-related vascular oxidative stress and endothelial dysfunction in rats with diet-induced obesity

  2021cites this paper
• Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

  2021influential citation
• Metabolomics applications in coronary artery disease personalized medicine.

  2021cites this paper
• The metabolic signatures of cardiometabolic diseases: Does the shared metabotype offer new therapeutic targets?

  2021cites this paper
• Metformin attenuates carotid neointimal hyperplasia by modulating the vascular smooth muscle cell phenotype transformation through upregulation of TET2, Nur77 and calponin

  2021cites this paper
• A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan

  2021cites this paper
• Association of Metformin and Abdominal Aortic Aneurysm Repair Outcomes.

  2021cites this paper
• Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis

  2021cites this paper
• Type 2 diabetes: evidence-based medicine approach to glucose-lowering therapy

  2021cites this paper
• Metformin activated AMPK signaling contributes to the alleviation of LPS-induced inflammatory responses in bovine mammary epithelial cells

  2021cites this paper
• In Vitro Alpha-Amylase Inhibitory Activity of Microencapsulated Cosmos caudatus Kunth Extracts

  2021cites this paper
• Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications

  2021cites this paper
• Metformin ameliorates bladder dysfunction in a rat model of partial bladder outlet obstruction.

  2021cites this paper
• Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism

  2021cites this paper
• Chronic Metformin Therapy is Associated with a Lower Risk of Hemorrhoid in Patients with Type 2 Diabetes Mellitus

  2021cites this paper